Quadrant Capital Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.99M Buy
6,313
+70
+1% +$35.2K 0.09% 178
2025
Q4
$2.91M Sell
6,243
-5
-0.1% -$2.32K 0.09% 175
2025
Q3
$2.66M Sell
6,248
-13
-0.2% -$5.04K 0.09% 182
2025
Q2
$2.4M Buy
6,261
+97
+2% +$35K 0.09% 189
2025
Q1
$2.13M Buy
6,164
+3,820
+163% +$1.23M 0.08% 168
2024
Q4
$704K Buy
2,344
+1
+0% +$349 0.05% 257
2024
Q3
$952K Buy
2,343
+49
+2% +$17.9K 0.07% 210
2024
Q2
$737K Buy
2,294
+178
+8% +$57.8K 0.05% 244
2024
Q1
$706K Buy
2,116
+2
+0.1% +$611 0.06% 254
2023
Q4
$572K Sell
2,114
-161
-7% -$39.8K 0.05% 273
2023
Q3
$560K Buy
2,275
+158
+7% +$43.2K 0.06% 252
2023
Q2
$642K Sell
2,117
-5
-0.2% -$1.39K 0.06% 208
2023
Q1
$560K Buy
2,122
+56
+3% +$14.2K 0.06% 239
2022
Q4
$496K Buy
2,066
+123
+6% +$27.5K 0.06% 237
2022
Q3
$357K Buy
1,943
+275
+16% +$54.8K 0.05% 277
2022
Q2
$280K Buy
1,668
+63
+4% +$13.5K 0.04% 338
2022
Q1
$402K Buy
1,605
+98
+7% +$24.6K 0.05% 266
2021
Q4
$387K Buy
1,507
+22
+1% +$5.38K 0.05% 272
2021
Q3
$360K Buy
1,485
+75
+5% +$18.3K 0.05% 253
2021
Q2
$292K Sell
1,410
-126
-8% -$25.7K 0.04% 287
2021
Q1
$289K Buy
1,536
+141
+10% +$24.9K 0.05% 262
2020
Q4
$229K Buy
1,395
+165
+13% +$24.1K 0.04% 274
2020
Q3
$153K Buy
1,230
+129
+12% +$16K 0.03% 322
2020
Q2
$107K Sell
1,101
-822
-43% -$85.5K 0.02% 436
2020
Q1
$173K Buy
1,923
+612
+47% +$79.2K 0.03% 412
2019
Q4
$178K Buy
1,311
+92
+8% +$12.4K 0.02% 710
2019
Q3
$134K Sell
1,219
-870
-42% -$112K 0.02% 742
2019
Q2
$272K Buy
2,089
+704
+51% +$89K 0.04% 443
2019
Q1
$167K Buy
1,385
+538
+64% +$72.3K 0.03% 563
2018
Q4
$93K Buy
847
+85
+11% +$11.4K 0.02% 637
2018
Q3
$97K Hold
762
0.03% 420
2018
Q2
$69K Buy
762
+139
+22% +$14.1K 0.02% 529
2018
Q1
$51K Buy
623
+21
+3% +$2.04K 0.02% 624
2017
Q4
$45K Buy
602
+37
+7% +$2.97K 0.02% 647
2017
Q3
$39K Sell
565
-48
-8% -$3.86K 0.02% 672
2017
Q2
$42K Hold
613
0.02% 613
2017
Q1
$46K Buy
613
+140
+30% +$11.7K 0.02% 594
2016
Q4
$30K Sell
473
-2
-0.4% -$150 0.02% 611
2016
Q3
$30K Sell
475
-142
-23% -$10.9K 0.02% 603
2016
Q2
$41K Buy
617
+161
+35% +$12.7K 0.03% 459
2016
Q1
$31K Buy
456
+216
+90% +$15.1K 0.02% 534
2015
Q4
$12K Buy
240
+41
+21% +$2.86K 0.01% 700
2015
Q3
$14K Buy
199
+16
+9% +$1.42K 0.01% 643
2015
Q2
$15K Buy
+183
New +$14.7K 0.01% 645

Other funds holding HCA

Quadrant Capital Group's HCA Position: Q1 2026 in Review

Quadrant Capital Group increased its HCA Healthcare (HCA) stake by 1.1% in Q1 2026, buying an estimated $35.2K and bringing the position to 6,313 shares worth $2.99M. The position accounts for 0.09% of the portfolio, ranked #178.

Quadrant Capital Group first reported a position in HCA in Q2 2015 and has held it in 44 quarters since. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Quadrant Capital Group held 6,313 shares of HCA Healthcare worth $2.99M as of Q1 2026.
  • Quadrant Capital Group bought 70 HCA Healthcare shares in Q1 2026, an estimated $35.2K.
  • HCA Healthcare made up 0.09% of Quadrant Capital Group's portfolio in Q1 2026, its #178 holding.
  • Quadrant Capital Group first reported a position in HCA Healthcare in Q2 2015 and has held it in 44 quarters since.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.